mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0012 |
1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0012 |
1 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.0012 |
1 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.00093 |
1 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.0014 |
1 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00086 |
1 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.00083 |
1 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
-0.00069 |
1 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.00056 |
1 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.00039 |
1 |